|
1
|
22/F
|
sciatic nerve
|
Yes
|
Yes
|
Tumor resection (Once)
|
β-Catenin ( +)
|
0
|
No progression
|
|
2
|
2/M
|
sciatic nerve
|
Yes
|
Yes
|
Surgical biopsy of sciatic nerve
|
β-Catenin ( +)
|
0
|
Progression of motor deficit, limb undergrowth and calf muscles atrophy
|
|
3
|
6/M
|
sciatic nerve
|
Yes
|
Yes
|
Tumor resection (Once); chemotherapy (Two cycles); HIFU (Six rounds);
|
β-Catenin ( +) CTNNB1 p. S45F mutation
|
Once (At the site of NMC)
|
Continuous tumor progression lead to above-knee amputation
|
|
4
|
10/F
|
brachial plexus
|
Yes
|
Yes
|
Tumor and involved brachial plexus resection, nerve transplantation
|
β-Catenin ( +)
|
0
|
No progression after nerve transplantation
|
|
5
|
2/M
|
sciatic nerve
|
Yes
|
Yes
|
Tumor resection (Three times); radiotherapy (A course)
|
β-Catenin ( +)
|
Twice (At the site of NMC)
|
No progression after last treatment
|
|
6
|
4/M
|
sciatic nerve
|
No
|
No
|
None
|
—
|
0
|
No progression
|
|
7
|
3/F
|
sciatic nerve
|
No
|
No
|
None
|
—
|
0
|
No progression
|
